India US Trade Deal Awaited; Trump Threatens 200% Tariff On Global Pharma Imports — Key Highlights
The Aug. 1 deadline to implement trade deals will not be moved, stated Trump.
Close: Key Highlights Of The Day
Here are the key highlights on the trade deal situation as of now:
Copper has been imposed with 50% tariffs.
Pharmaceuticals have been threatened with 200%, and word is likely on the sector in a year.
The Aug. 1 deadline to implement trade deals will not be moved.
All members of BRICS will be charged 10% tariffs.
With this, NDTV Profit bids adieu, as our latest coverage on the US trade deal front simultaneously begins here. See you on a different URL!
This live blog has ended. For more action as it unfolds, follow us here.
Live: Nifty Pharma's Performance On Wednesday
Despite Trump's 200% tariff threat, the pharmaceutical sector saw trading end on a strong note, with the Nifty Pharma index outperforming a decline in the benchmark Nifty 50 to end 0.19% higher.
Here are the top gainers and losers:
Live: Copper Futures Slide On Tariff Woes
LME copper slid as much as 2.4%. The metal retreated 2.9% in New York after Tuesday’s 13% surge.
News Live: Tariff Letters Rolled Out, India Still Awaiting
India is still awaiting the finalisation of an interim trade deal as US President Donald Trump intensifies his tariff agenda ahead of the Aug. 1 rollout.
News Live: Nirmal Bang Bullish On Copper In Long-Term
Nirmal Bang's Kunal Shah commented on the 50% tariff on Copper by US, noting that China is expected to see tepid demand growth, while mines are struggling to meet environmental safety standards. Despite these challenges, he remains bullish on copper from a long-term perspective.
